Fatih AKBULUT, Faruk ÖZGÖR, Erkan SÖNMEZAY, Akif ERBİN, Abdülmüttalip ŞİMŞEK, Gökhan GÜRBÜZ

Nükseden böbrek tümörünü taklit eden duedonum gastrointestinal stromal tümörü: Vaka sunumu

Duedonum gastrointestinal stromal tümörü GIST , belirsiz klinik semptomları olan ve tüm GIST’in az bir kısmını oluşturan çok nadir görülen bir tümördür. Radyolojik görüntülemede böbreğin musinöz tubüler ve iğsi hücreli tümörünün rekürrensini taklit eden asemptomatik duedonum GIST’i olan vakayı sunduk

Anahtar Kelimeler:

Duedonum, GIST, böbrek tümörü, rekürrens, imatinib

Duodenal gastrointestinal stromal tumor mimicking recurrent renal carcinoma

Duodenal gastrointestinal stromal tumors GISTs are seen very rare and small part of GISTs which has variable clinical symptoms. We present an asymptomatic duodenal GIST mimicking recurrence of mucinous tubular and spindle cell carcinoma MTSCC of kidney in radiological imaging studies

Keywords:

Duodenum, GIST, renal carcinoma, recurrence, imatinib,

___

Arafah M, Zaidi SN. Mucinous tubular and spindle cell carcinoma of the kidney with sarcomatoid transformation. Saudi J Kidney Dis Transp 2013; 24:557-60.
Chrysikos D, Zagouri F, Sergentanis TN et al. Mucinous tubular and spindle cell carcinoma of the kidney: a case report. Case Rep Oncol 2012;5 :347-53.
Hussain M, Ud Din N, Azam M et al. Mucinous tubular and spindle cell carcinoma of kidney: a clinicopathologic study of six cases. Indian J Pathol Microbio. 2012; 55:439- 42.
Fletcher CD, Berman JJ, Corless C et al. Diagnosis of gas- trointestinal stromal tumors: a consensus approach. Hum Pathol 2002;33: 459–65.
Antoch G, Herrmann K, Heusner TA et al. Imaging proce- dures for gastrointestinal stromal tumors. Radiologe 2009; 49: 1109-1116.
Winfield RD, Hochwald SN, Vogel SB et al. Presentation and management of gastrointestinal stromal tumors of the duodenum. Am Surg 2006;72: 719–22.
Asakawa M, Sakamoto Y, Kajiwara T et al. Simple segmen- tal resection of the second portion of the duodenum for the treatment of gastrointestinal stromal tumors. Langen- becks Arch Surg 2008;393:605–9.
Cohen MH, Cortazar P, Justice R et al. Approval summary: imatinib mesylate in the adjuvant treatment of malignant gastrointestinal stromal tumors. Oncologis. 2010;15: 300– 7.
Connolly EM, Gaffney E, Reynolds JV. Gastrointestinal stromal tumours. Br J Surg 2003;90: 1178–86.
Goh BK, Chow PK, Kesavan S et al. Outcome after surgi- cal treatment of suspected gastrointestinal stromal tumors involving the duodenum: is limited resection appropriate? J Surg Oncol 2008;97:388–91.
Miettinen M, Kopczynski J, Makhlouf HR et al. Gastro- intestinal stromal tumors, intramural leiomyomas, and leiomyosarcomas in the duodenum: a clinicopathologic, immunohistochemical, and molecular genetic study of 167 cases. Am J Surg Pathol 2003; 27: 625-641.
Mucciarini C, Rossi G, Bertolini F et al. Incidence and clin- icopathologic features of gastrointestinal stromal tumors. A population-based study. BMC Cancer 2007;7: 230.
Chung JC, Chu CW, Cho GS et al. Management and out- come of gastrointestinal stromal tumors of the duodenum. J Gastrointest Surg 2010;14: 880–3.
Yang WL, Yu R, Wu YJ et al. Duodenal gastrointestinal stromal tumor: clinical, pathologic, immunohistochemi- cal characteristics, and surgical prognosis. J Surg Oncol 2009;100:606–10.
Hoeppner J, Kulemann B, Marjanovic G et al. Limited re- section for duodenal gastrointestinal stromal tumors: Sur- gical management and clinical outcome. World J Gastruin- test Surg 2013; 5:16-21.
Hong X, Choi H, Loyer EM, et al. Gastrointestinal stromal tumor: role of CT in diagnosis and in response evaluation and surveillance after treatment with imatinib. Radio- graphics 2006;26:481–95.
Joensuu H. Gastrointestinal stromal tumor (GIST). Ann Oncol 2006; 17:280–6.
Pierie JP, Choudry U, Muzikansky A et al. The effect of surgery and grade on outcome of gastrointestinal stromal tumors. Arch Surg 2001;136:383–9.
Machado NO, Chopra PJ, Al-Haddabi IH et al. Large duo- denal gastrointestinal stromal tumor presenting with acute bleeding managed by a Whipple resection. A review of surgical options and the prognostic indicators of outcome. JOP 2011;12:194–9.
Lanuke K, Bathe OF, Mack LA. Local excision of duodenal gastrointestinal stromal tumor. J Surg Oncol 2007;95:267– 9.
Demetri GD, von Mehren M, Blanke CD et al. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med 2002;347:472–80.
Goh BK, Chow PK, Chuah KL et al. Pathologic, radiologic and PET scan response of gastrointestinal stromal tumors after neoadjuvant treatment with imatinib mesylate. Eur J Surg Oncol 2006;32:961–3.
Joensuu H, Eriksson M, Sundby HK et al. One and three years of adjuvant imatinib for operable gastrointestinal stromal tumor: a randomized trial. JAMA 2012; 307:1265- 72.
National Comprehensive Cancer Network. National Com- prehensive Cancer Network (NCCN), version I.2012. Available at: http://www.nccn.org/. Accessed November 19, 2012.